Category

Uncategorized

Achelous Partners Advises Plasma Services Group on its sale to Fujirebio Diagnostics, Inc.

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings Inc. (hereinafter...

Achelous Partners Advises Curia on its sale of a US CDMO site to Siegfried

The new site, which specializes in early-phase development and manufacturing services with an experienced...

Achelous Partners Advises A4P Consulting Ltd on its sale to LabConnect

A4P is headquartered in Discovery Park, Sandwich, Kent, UK, with a wholly-owned subsidiary in Appenzell,...

Achelous Partners Advises Six Degrees Medical on its sale to Reverba

Reverba’s acquisition will enable the integration of Six Degrees’ comprehensive suite of medical...

Achelous Partners Advises Bio X Cell on its sale to Windjammer Capital

Bio X Cell is a leading producer of monoclonal antibodies (mAbs) for use in both in vivo and in vitro...

December 13, 2023

Achelous Advises Symbio and ProInnovera on their respective sales to Archimed

Achelous, a leading advisory firm specializing in mergers and acquisitions, has successfully facilitated the...

November 17, 2023

Achelous Partners Advises Symbio and ProInnovera on their respective sales to Archimed

Global Private Equity healthcare specialist ARCHIMED has acquired and simultaneously merged US-based Symbio,...

November 17, 2023

Achelous Advises Pharmalog on its sale to Henko Partners to form Astrum

Achelous, a leading M&A advisory firm, is pleased to announce its role in advising Pharmalog on its sale...

November 8, 2023

Achelous Partners Advises Pharmalog on its sale to Henko Partners to form Astrum

Henko Partners launches AstrumCRO after investing in BlueClinical and Pharmalog

November 8, 2023

1
2
3
…
11
Next

Get in Touch

Get Expert Advice and
Propel Your Business Forward

Ready to take your business to the next level? Our team of experts are here to provide the strategic advice and tailored solutions you need to excel.